Trial Profile
Safety and efficacy of vildagliptin, sitagliptin and linagliptin in Chinese patients with type 2 diabets
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Sitagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 23 Sep 2016 New trial record